Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by macman1519on May 11, 2018 10:07am
220 Views
Post# 28017728

RE:RE:RE:RE:RE:RE:PP

RE:RE:RE:RE:RE:RE:PP

The weak point of view has come back!! It is:  this is a small pp to tide us over to better results and a stronger share price where we can do a bigger pp!! That view is negative, unsure and fits nicely into the choirs agenda of selling long shareholders out to future pp subscribers!!!

ONCE AGAIN, FUK YOUR PPS, IF WE HAVE WHAT WE BELIEVE WE HAVE, BRING PHARMA ON BOARD AND EVERYTHING IS SOLVED!!!  NO FUKIN PPS ARE NEEDED!!!!!!!!!!!!
END OF STORY !


bionicjoe wrote: Some posters and maybe the company too are hanging their hat on wait and the share price will be higher for the next PP. Hasn't that been the story since this whole process started with the market ending up confounding everybody? Whatever happened to the company strategy from not too long ago to wait until the sp reached just under a dollar and then do a raise? Life has a way of throwing you curve balls and this company seems to have more than its share of those. They need a strategic partner, case closed. The job they're tackling is just too big and expensive for a micro cap to tackle it alone.

Bullboard Posts